SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against SARS-CoV-2 Delta and Omicron that can be predicted by anti-S antibody concentrations in serological assays

Alina Seidel, Bernd Jahrsdörfer, Sixten Körper, Dan Albers, Pascal von Maltitz, Rebecca Müller, Ramin Lotfi, Patrick Wuchter, Harald Klüter, Michael Schmidt, Jan Münch, Hubert Schrezenmeier
doi: https://doi.org/10.1101/2022.01.17.22269201

Article usage

Article usage: January 2022 to May 2025

AbstractFullPdf
Jan 2022178923475
Feb 20221881672
Mar 20221431627
Apr 202258217
May 202277728
Jun 202285621
Jul 20224305
Aug 20223469
Sep 202262320
Oct 20223006
Nov 202229110
Dec 20222818
Jan 202324116
Feb 202329510
Mar 20232615
Apr 20232536
May 20231324
Jun 20231442
Jul 20231217
Aug 2023171113
Sep 20232554
Oct 202320410
Nov 20232190
Dec 20232038
Jan 2024731
Feb 20241855
Mar 20241859
Apr 202411511
May 20241425
Jun 20241028
Jul 20249312
Aug 20242788
Sep 202420310
Oct 20241577
Nov 202417412
Dec 2024914
Jan 20251676
Feb 20251272
Mar 2025361813
Apr 202534212
May 20251037
Back to top
Posted January 17, 2022.
Download PDF
Data/Code
Email
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against SARS-CoV-2 Delta and Omicron that can be predicted by anti-S antibody concentrations in serological assays
Alina Seidel, Bernd Jahrsdörfer, Sixten Körper, Dan Albers, Pascal von Maltitz, Rebecca Müller, Ramin Lotfi, Patrick Wuchter, Harald Klüter, Michael Schmidt, Jan Münch, Hubert Schrezenmeier
medRxiv 2022.01.17.22269201; doi: https://doi.org/10.1101/2022.01.17.22269201
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area